Comparative Clinical and Economic Outcomes among Venous Thromboembolism Patients who Initiated Apixaban or Warfarin in the United States Medicare Population (VTE CER in Medicare)

First published 19/07/2018

Last updated 02/06/2020

EU PAS number:

EUPAS24902

Study

Finalised

Documents

Study protocol

Initial protocol

SIMR_Pfizer_Protocol_Medicare_VTE_07JUNE_clean

English (922.32 KB - PDF)View document

Study results

Final Report_Medicare_VTE

English (345.28 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs